Microbiology of Gram-negative Bacteria in Cystic Fibrosis

Presented by

Professor Dr. Samantha Sottotetti

About this talk

Learn about the primary pathogens isolated in cystic fibrosis patients and consider these microorganisms’ relative antimicrobial susceptibility. How do differing intrinsic resistance values from international authorities impact antibiotic management? What interpretive category breakpoints can be used with these opportunistic, environmental pathogenic, non-fermenting, Gram-negative bacteria in cystic fibrosis patients? In this workshop, recorded at the 29th European Congress of Clinical Microbiology & Infectious Diseases, Dr. Samantha Sottotetti explains the importance of cystic fibrosis microbiology in Gram-negative, non-fermenting bacteria isolated from the respiratory tract of cystic fibrosis patients. After viewing this webinar, you will be able to: •Understand what bacteria colonize lungs of cystic fibrosis patients, and how MIC testing is performed •Identify characteristics of colonization and phenotypes of P. aeruginosa, the major Gram-negative organism •Describe other opportunistic pathogens—including A. xylosidans, S. maltophilia and B. cepacia—and antibiotic resistance for each organism P.A.C.E. credit is available for your participation.* Ideal For: Microbiologist, Laboratory Director, Physician, Pathologist Presenter: Professor Dr. Samantha Sottotetti, Cystic Fibrosis Microbiology Laboratory *Beckman Coulter Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. These credits are recognized by the State of California. Most programs also provide State of Florida credits (with valid license number). At this time, we cannot issue continuing education credits for those who provide healthcare (or work for an institution that provides healthcare) in Massachusetts or Vermont.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (70)
Subscribers (21795)
Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. Beckman Coulter’s instruments, systems and tests help streamline processes to enhance efficiency, reduce costs and speed the delivery of results. For more than 75 years, Beckman Coulter has been a global leader devoted to providing solutions to laboratories of all sizes – offering a broad portfolio of chemistry, immunoassay, hematology, urinalysis, automation and information systems. Beckman Coulter is, and always has been, singularly devoted to moving science, innovation and the lab forward.